Forbes Medi-Tech Sells Andro Business

June 23, 2003

1 Min Read
Forbes Medi-Tech Sells Andro Business


Forbes Medi-Tech Sells Andro Business

VANCOUVER, British ColumbiaForbes Medi-Tech Inc. (NASDAQ:FMTI)sold its pharmaceutical fine chemicals business, which focused on processtechnologies for androstenedione and androstadienedione, to an unnamedmulti-national pharmaceutical company. The sale gave the company $1.9 million ingross proceeds. This initiative is in line with Forbes streamlined focus ongenerating revenue for its nutraceutical business.

For more information, visit www.forbesmedi.comor Booth #4807 at the IFT Food Expo.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like